Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression Profiles and Prognostic Roles of m6A Writers, Erasers and Readers in Gastric Cancer
Jingjing Jing, Xu Zhao, Hao Li, et al.
Future Oncology (2021) Vol. 17, Iss. 20, pp. 2605-2620
Closed Access | Times Cited: 22

Showing 22 citing articles:

m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer
Weihong Xu, Yanan Lai, Yunqi Pan, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 57
YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m6A-dependent manner
Yuxiang Lin, Xuan Jin, Qian Nie, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 2, pp. 83-83
Open Access | Times Cited: 42
The inhibition of YTHDF3/m6A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer
Sheng Zhong, Quanwei Guo, Xiaona Chen, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 3, pp. 916-936
Open Access | Times Cited: 12
ALKBH5 suppresses gastric cancer tumorigenesis and metastasis by inhibiting the translation of uncapped WRAP53 RNA isoforms in an m6A-dependent manner
Zi‐Qi Zheng, Feizhi Lin, Baiwei Zhao, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Novel evidence for m6A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer
Tadanobu Shimura, Raju Kandimalla, Yoshinaga Okugawa, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 2, pp. 228-237
Open Access | Times Cited: 47
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Journal of Molecular Endocrinology (2022) Vol. 70, Iss. 2
Open Access | Times Cited: 32
Epigenetic regulation of autophagy in gastrointestinal cancers
Saeid Ghavami, Mozhdeh Zamani, Mazaher Ahmadi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 11, pp. 166512-166512
Open Access | Times Cited: 29
N6-methyladenosine RNA modification in stomach carcinoma: Novel insights into mechanisms and implications for diagnosis and treatment
Zhengmao Lu, Zhaojie Lyu, Peixin Dong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167793-167793
Closed Access
Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4225-4225
Open Access | Times Cited: 11
The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets
Gaofeng Li, Qiru Fu, Cong Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Changes in m6A in Steatotic Liver Disease
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10
N6-methylation in the development, diagnosis, and treatment of gastric cancer
Jiaxin Wang, Guiping Zhao, Yan Zhao, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 1, pp. 5-21
Open Access | Times Cited: 3
Role of N6-methyladenosine RNA modification in gastric cancer
Siqi Ding, Xue-Ping Zhang, Jun‐Peng Pei, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
The RNA m6A writer RBM15 contributes to the progression of esophageal squamous cell carcinoma by regulating miR-3605-5p/KRT4 pathway
Huan Wang
Heliyon (2024) Vol. 10, Iss. 2, pp. e24459-e24459
Open Access | Times Cited: 2
Construction of a survival nomogram for gastric cancer based on the cancer genome atlas of m6A-related genes
Xiaokang Wang, Kexin Xu, Xueyi Liao, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 10
FTO Promotes the Stemness of Gastric Cancer Cells
Mengqing Li, Xuan Wu, Li Guan, et al.
DNA and Cell Biology (2023) Vol. 42, Iss. 7, pp. 411-420
Closed Access | Times Cited: 4
Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer
Shi Zhang, Guanghao Kuang, Yao Huang, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Progress and application of epitranscriptomic m 6 A modification in gastric cancer
Yitian Xu, Chen Huang
RNA Biology (2022) Vol. 19, Iss. 1, pp. 885-896
Open Access | Times Cited: 6
The m6A RNA Modification Quantity and mRNA Expression Level of RNA Methylation-Related Genes in Head and Neck Squamous Cell Carcinoma Cell Lines and Patients
Kamila Romanowska, Agnieszka Anna Rawłuszko-Wieczorek, Łukasz Marczak, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 908-908
Open Access | Times Cited: 8
Emerging Roles of N6-Methyladenosine Demethylases and Its Interaction with Environmental Toxicants in Digestive System Cancers
Caiping Liu, Sheng Yang, Yanqiu Zhang, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 7101-7114
Open Access | Times Cited: 8
Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15
Limin Yue, Rongguang Zhang, Shuaiyin Chen, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 4
METTL3 as a potential therapeutic target in gastric cancer
Zhigang Yu, Yang Yang
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1

Scroll to top